The mouse kappa immunoglobulin gene contains a DNA sequence that binds tightly to the nuclear matrix, to topoisomerase II, and to other proteins known to specify higher order chromatin structures. This sequence has been termed a matrix association region (MAR). The mouse kappa gene MAR is adjacent to the intronic transcriptional enhancer. This juxtaposition has been evolutionarily conserved in the rabbit and human kappa genes. In previous studies we found that deletion of the MAR resulted in lower and erratic expression of a rearranged mouse kappa gene, when it was stably integrated into ectopic sites in either mouse plasmacytoma cells or into the mouse germline for the production of transgenic mice. Here we propose to take advantage of the powerful technique of site directed integration in embryonic stem cells to determine the functional significance of this MAR in its natural chromosomal location by addressing the following specific aims: 1. The possible function of the MAR in recombination will be explored in germline alleles containing a MAR deletion introduced by site-directed integration into: a. mouse pre-B cells capable of undergoing V-J joining in culture b. mouse embryonic stem cells for the generation of knockout mice 2. The possible function of the MAR in transcription will be explored in the systems described under specific aim 1. Levels of germline transcripts arising from unrearranged C-kappa-O and V-kappa-O alleles and spliced transcripts arising from rearranged alleles will be assayed in pre-B and B cells, respectively. If its is found in specific aim 1 that the MAR is absolutely required for recombination, then a rearranged kappa allele containing a MAR deletion will be site-directed-integrated into plasmacytoma cells for transcription studies. 3. The possible function of the MAR in somatic hypermutation will be explored in the system described under specific aim 1b, if it is found that the MAR is not absolutely required for recombination. The antiarsonate response will be assessed specifically. 4. The sequence requirements of the MAR to perform functions uncovered from the above studies will be evaluated by mutagenesis and heterologous MAR substitution experiments.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM051585-04
Application #
2459583
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1994-08-01
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
2000-07-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390